Mobius Therapeutics, LLC

The only FDA approved formulation of mitomycin-c with an ophthalmic indication. Orphan drug status. Patent exclusivity until 2029.

  • Stage $1M in TTM Revenue
  • Industry Biotechnology
  • Location St. Louis, MO, USA
  • Currency USD
  • Founded April 2006
  • Employees 9
  • Incorporation Type LLC
  • Website mobiustherapeutics.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free